Albertsons Companies Inc (N:ACI)

Sector:  Consumer Non-Cyclicals Industry:  Food Retail & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 250 E Parkcenter Blvd
BOISE ID 83706-3940
Tel: N/A
Website: https://www.albertsonscompanies.com
IR: See website
<
Key People
James L. Donald
Co-Chairman of the Board
Omer Gajial
Executive Vice President - Health, Chief Digital Officer
Chan W. Galbato
Co-Chairman of the Board
Sharon L. Mccollam
President, Chief Financial Officer
Vivekanan Sankaran
Chief Executive Officer, Director
Brian Kevin Turner
Vice Chairman of the Board
Susan Morris
Chief Operations Officer, Executive Vice President
Michael Theilmann
Chief Human Resource Officer, Executive Vice President
Anuj Dhanda
Executive Vice President, Chief Technology and Transformation Officer
Thomas M. Moriarty
Executive Vice President, General Counsel
   
Business Overview
Albertsons Companies, Inc. is a food and drug retailer in the United States. The Company is engaged in the operation of food and drug retail stores that offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel and other items and services in its stores or through digital channels. The Company operates approximately 2,271 stores across 34 states and the District of Columbia under 24 banners including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, Market Street, Haggen, Kings Food Markets and Balducci's Food Lovers Market. The Company operates approximately 1,722 pharmacies, 1,328 in-store branded coffee shops, 401 associated fuel centers, 22 dedicated distribution centers, 19 manufacturing facilities and various digital platforms. Its own brands include Signature SELECT, Open Nature, Signature Cafe, Lucerne, Waterfront BISTRO, Primo Taglio, Signature Care, Signature Reserve and Value Corner.
Financial Overview
For the fiscal year ended 24 February 2024, Albertsons Companies Inc revenues increased 2% to $79.24B. Net income applicable to common stockholders increased 7% to $1.3B. Revenues reflect Pharmacy segment increase of 22% to $8.24B, Retail Sales -Pharmacy increase of 22% to $8.24B. Net income benefited from Depreciation/Amortization in SGA decrease of 2% to $1.61B (expense). Dividend per share remained flat at $0.48.
Employees: 108,300 as of Feb 24, 2024
Reporting Currency: U.S. Dollars
Enterprise value: $19,562M as of Feb 24, 2024
Annual revenue (TTM): $79,238M as of Feb 24, 2024
EBITDA (TTM): $4,110M as of Feb 24, 2024
Net annual income (TTM): $1,295M as of Feb 24, 2024
Free cash flow (TTM): $351.20M as of Feb 24, 2024
Net Debt Last Fiscal Year: $7,857M as of Feb 24, 2024
Shares outstanding: 577,407,663 as of Apr 18, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.